Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]
Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies
Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired […]
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer
ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment […]
GSK Completes Acquisition of Sierra Oncology
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. […]
VistaPath Raises $4M to Modernize Pathology Labs Using Computer Vision and Artificial Intelligence
VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that […]
PureCycle Announces Key Leadership Changes, New Chief Executive Officer
Today, PureCycle Technologies, Inc. (NASDAQ: PCT) announced three key leadership changes effective August 5, 2022, that are […]
Tomorrow Health Raises $60 Million Series B to Scale Quality Home-Based Care
Tomorrow Health, a home-based care company, closed a $60 million Series B round, bringing its […]
Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company […]
Evolved By Nature Raises $120M Series C, Led by Teachers' Venture Growth, to Scale Sustainable Activated Silk™ Technology for Global Impact
Evolved By Nature, the company creating a proprietary library of Activated Silk™ molecules from natural […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more